「MarketsandMarkets」タグアーカイブ

カテゴリー： 医療, 世界, GlobalInfoResearch
GlobalInfoResearchが出版した調査資料（GIR773KT3330）・商品コード：GIR773KT3330
・発行会社（調査会社）：GlobalInfoResearch
・発行日：2024年12月
・ページ数：約100
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Corporate License（法人閲覧用）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

According to our (Global Info Research) latest study, the global Digital Therapeutics market size was valued at USD 455.1 million in 2023 and is forecast to a readjusted size of USD 1689.2 million by 2030 with a CAGR of 20.6% during review period.

Digital therapeutic is a digitized health solution, which utilizes digital and online health technologies to treat various medical and psychological conditions.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The Global Info Research report includes an overview of the development of the Digital Therapeutics industry chain, the market status of Diabetes (Software, Devices), Obesity (Software, Devices), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Digital Therapeutics.

Regionally, the report analyzes the Digital Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Digital Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Key Features:
The report presents comprehensive understanding of the Digital Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Digital Therapeutics industry.

The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Software, Devices).

Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Digital Therapeutics market.

Regional Analysis: The report involves examining the Digital Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.

Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Digital Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.

The report also involves a more granular approach to Digital Therapeutics:
Company Analysis: Report covers individual Digital Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.

Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Digital Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Diabetes, Obesity).

Technology Analysis: Report covers specific technologies relevant to Digital Therapeutics. It assesses the current state, advancements, and potential future developments in Digital Therapeutics areas.

Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Digital Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.

Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.

Market Segmentation
Digital Therapeutics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Market segment by Type
Software
Devices

Market segment by Application
Diabetes
Obesity
Cardio Vascular Diseases (CVD)
Central Nervous System (CNS) Disease
Gastrointestinal Disorders (GID)
Respiratory Diseases
Smoking Cessation
Others

Market segment by players, this report covers
Proteus Digital Health
Omada Health
WellDoc
2Morrow
Livongo Health
Propeller Health
Twine Health
Canary Health

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Digital Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Digital Therapeutics, with revenue, gross margin and global market share of Digital Therapeutics from 2019 to 2024.
Chapter 3, the Digital Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Digital Therapeutics market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Digital Therapeutics.
Chapter 13, to describe Digital Therapeutics research findings and conclusion.

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of Digital Therapeutics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Digital Therapeutics by Type
1.3.1 Overview: Global Digital Therapeutics Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Digital Therapeutics Consumption Value Market Share by Type in 2023
1.3.3 Software
1.3.4 Devices
1.4 Global Digital Therapeutics Market by Application
1.4.1 Overview: Global Digital Therapeutics Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Diabetes
1.4.3 Obesity
1.4.4 Cardio Vascular Diseases (CVD)
1.4.5 Central Nervous System (CNS) Disease
1.4.6 Gastrointestinal Disorders (GID)
1.4.7 Respiratory Diseases
1.4.8 Smoking Cessation
1.4.9 Others
1.5 Global Digital Therapeutics Market Size & Forecast
1.6 Global Digital Therapeutics Market Size and Forecast by Region
1.6.1 Global Digital Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Digital Therapeutics Market Size by Region, (2019-2030)
1.6.3 North America Digital Therapeutics Market Size and Prospect (2019-2030)
1.6.4 Europe Digital Therapeutics Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Digital Therapeutics Market Size and Prospect (2019-2030)
1.6.6 South America Digital Therapeutics Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Digital Therapeutics Market Size and Prospect (2019-2030)

2 Company Profiles
2.1 Proteus Digital Health
2.1.1 Proteus Digital Health Details
2.1.2 Proteus Digital Health Major Business
2.1.3 Proteus Digital Health Digital Therapeutics Product and Solutions
2.1.4 Proteus Digital Health Digital Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Proteus Digital Health Recent Developments and Future Plans
2.2 Omada Health
2.2.1 Omada Health Details
2.2.2 Omada Health Major Business
2.2.3 Omada Health Digital Therapeutics Product and Solutions
2.2.4 Omada Health Digital Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Omada Health Recent Developments and Future Plans
2.3 WellDoc
2.3.1 WellDoc Details
2.3.2 WellDoc Major Business
2.3.3 WellDoc Digital Therapeutics Product and Solutions
2.3.4 WellDoc Digital Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 WellDoc Recent Developments and Future Plans
2.4 2Morrow
2.4.1 2Morrow Details
2.4.2 2Morrow Major Business
2.4.3 2Morrow Digital Therapeutics Product and Solutions
2.4.4 2Morrow Digital Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 2Morrow Recent Developments and Future Plans
2.5 Livongo Health
2.5.1 Livongo Health Details
2.5.2 Livongo Health Major Business
2.5.3 Livongo Health Digital Therapeutics Product and Solutions
2.5.4 Livongo Health Digital Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Livongo Health Recent Developments and Future Plans
2.6 Propeller Health
2.6.1 Propeller Health Details
2.6.2 Propeller Health Major Business
2.6.3 Propeller Health Digital Therapeutics Product and Solutions
2.6.4 Propeller Health Digital Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Propeller Health Recent Developments and Future Plans
2.7 Twine Health
2.7.1 Twine Health Details
2.7.2 Twine Health Major Business
2.7.3 Twine Health Digital Therapeutics Product and Solutions
2.7.4 Twine Health Digital Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Twine Health Recent Developments and Future Plans
2.8 Canary Health
2.8.1 Canary Health Details
2.8.2 Canary Health Major Business
2.8.3 Canary Health Digital Therapeutics Product and Solutions
2.8.4 Canary Health Digital Therapeutics Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Canary Health Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Digital Therapeutics Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Digital Therapeutics by Company Revenue
3.2.2 Top 3 Digital Therapeutics Players Market Share in 2023
3.2.3 Top 6 Digital Therapeutics Players Market Share in 2023
3.3 Digital Therapeutics Market: Overall Company Footprint Analysis
3.3.1 Digital Therapeutics Market: Region Footprint
3.3.2 Digital Therapeutics Market: Company Product Type Footprint
3.3.3 Digital Therapeutics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
4.1 Global Digital Therapeutics Consumption Value and Market Share by Type (2019-2024)
4.2 Global Digital Therapeutics Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
5.1 Global Digital Therapeutics Consumption Value Market Share by Application (2019-2024)
5.2 Global Digital Therapeutics Market Forecast by Application (2025-2030)

6 North America
6.1 North America Digital Therapeutics Consumption Value by Type (2019-2030)
6.2 North America Digital Therapeutics Consumption Value by Application (2019-2030)
6.3 North America Digital Therapeutics Market Size by Country
6.3.1 North America Digital Therapeutics Consumption Value by Country (2019-2030)
6.3.2 United States Digital Therapeutics Market Size and Forecast (2019-2030)
6.3.3 Canada Digital Therapeutics Market Size and Forecast (2019-2030)
6.3.4 Mexico Digital Therapeutics Market Size and Forecast (2019-2030)

7 Europe
7.1 Europe Digital Therapeutics Consumption Value by Type (2019-2030)
7.2 Europe Digital Therapeutics Consumption Value by Application (2019-2030)
7.3 Europe Digital Therapeutics Market Size by Country
7.3.1 Europe Digital Therapeutics Consumption Value by Country (2019-2030)
7.3.2 Germany Digital Therapeutics Market Size and Forecast (2019-2030)
7.3.3 France Digital Therapeutics Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Digital Therapeutics Market Size and Forecast (2019-2030)
7.3.5 Russia Digital Therapeutics Market Size and Forecast (2019-2030)
7.3.6 Italy Digital Therapeutics Market Size and Forecast (2019-2030)

8 Asia-Pacific
8.1 Asia-Pacific Digital Therapeutics Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Digital Therapeutics Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Digital Therapeutics Market Size by Region
8.3.1 Asia-Pacific Digital Therapeutics Consumption Value by Region (2019-2030)
8.3.2 China Digital Therapeutics Market Size and Forecast (2019-2030)
8.3.3 Japan Digital Therapeutics Market Size and Forecast (2019-2030)
8.3.4 South Korea Digital Therapeutics Market Size and Forecast (2019-2030)
8.3.5 India Digital Therapeutics Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Digital Therapeutics Market Size and Forecast (2019-2030)
8.3.7 Australia Digital Therapeutics Market Size and Forecast (2019-2030)

9 South America
9.1 South America Digital Therapeutics Consumption Value by Type (2019-2030)
9.2 South America Digital Therapeutics Consumption Value by Application (2019-2030)
9.3 South America Digital Therapeutics Market Size by Country
9.3.1 South America Digital Therapeutics Consumption Value by Country (2019-2030)
9.3.2 Brazil Digital Therapeutics Market Size and Forecast (2019-2030)
9.3.3 Argentina Digital Therapeutics Market Size and Forecast (2019-2030)

10 Middle East & Africa
10.1 Middle East & Africa Digital Therapeutics Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Digital Therapeutics Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Digital Therapeutics Market Size by Country
10.3.1 Middle East & Africa Digital Therapeutics Consumption Value by Country (2019-2030)
10.3.2 Turkey Digital Therapeutics Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Digital Therapeutics Market Size and Forecast (2019-2030)
10.3.4 UAE Digital Therapeutics Market Size and Forecast (2019-2030)

11 Market Dynamics
11.1 Digital Therapeutics Market Drivers
11.2 Digital Therapeutics Market Restraints
11.3 Digital Therapeutics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry

12 Industry Chain Analysis
12.1 Digital Therapeutics Industry Chain
12.2 Digital Therapeutics Upstream Analysis
12.3 Digital Therapeutics Midstream Analysis
12.4 Digital Therapeutics Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Digital Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Digital Therapeutics Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Digital Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Digital Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Proteus Digital Health Company Information, Head Office, and Major Competitors
Table 6. Proteus Digital Health Major Business
Table 7. Proteus Digital Health Digital Therapeutics Product and Solutions
Table 8. Proteus Digital Health Digital Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Proteus Digital Health Recent Developments and Future Plans
Table 10. Omada Health Company Information, Head Office, and Major Competitors
Table 11. Omada Health Major Business
Table 12. Omada Health Digital Therapeutics Product and Solutions
Table 13. Omada Health Digital Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Omada Health Recent Developments and Future Plans
Table 15. WellDoc Company Information, Head Office, and Major Competitors
Table 16. WellDoc Major Business
Table 17. WellDoc Digital Therapeutics Product and Solutions
Table 18. WellDoc Digital Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. WellDoc Recent Developments and Future Plans
Table 20. 2Morrow Company Information, Head Office, and Major Competitors
Table 21. 2Morrow Major Business
Table 22. 2Morrow Digital Therapeutics Product and Solutions
Table 23. 2Morrow Digital Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. 2Morrow Recent Developments and Future Plans
Table 25. Livongo Health Company Information, Head Office, and Major Competitors
Table 26. Livongo Health Major Business
Table 27. Livongo Health Digital Therapeutics Product and Solutions
Table 28. Livongo Health Digital Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Livongo Health Recent Developments and Future Plans
Table 30. Propeller Health Company Information, Head Office, and Major Competitors
Table 31. Propeller Health Major Business
Table 32. Propeller Health Digital Therapeutics Product and Solutions
Table 33. Propeller Health Digital Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Propeller Health Recent Developments and Future Plans
Table 35. Twine Health Company Information, Head Office, and Major Competitors
Table 36. Twine Health Major Business
Table 37. Twine Health Digital Therapeutics Product and Solutions
Table 38. Twine Health Digital Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Twine Health Recent Developments and Future Plans
Table 40. Canary Health Company Information, Head Office, and Major Competitors
Table 41. Canary Health Major Business
Table 42. Canary Health Digital Therapeutics Product and Solutions
Table 43. Canary Health Digital Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Canary Health Recent Developments and Future Plans
Table 45. Global Digital Therapeutics Revenue (USD Million) by Players (2019-2024)
Table 46. Global Digital Therapeutics Revenue Share by Players (2019-2024)
Table 47. Breakdown of Digital Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 48. Market Position of Players in Digital Therapeutics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 49. Head Office of Key Digital Therapeutics Players
Table 50. Digital Therapeutics Market: Company Product Type Footprint
Table 51. Digital Therapeutics Market: Company Product Application Footprint
Table 52. Digital Therapeutics New Market Entrants and Barriers to Market Entry
Table 53. Digital Therapeutics Mergers, Acquisition, Agreements, and Collaborations
Table 54. Global Digital Therapeutics Consumption Value (USD Million) by Type (2019-2024)
Table 55. Global Digital Therapeutics Consumption Value Share by Type (2019-2024)
Table 56. Global Digital Therapeutics Consumption Value Forecast by Type (2025-2030)
Table 57. Global Digital Therapeutics Consumption Value by Application (2019-2024)
Table 58. Global Digital Therapeutics Consumption Value Forecast by Application (2025-2030)
Table 59. North America Digital Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 60. North America Digital Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 61. North America Digital Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 62. North America Digital Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 63. North America Digital Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 64. North America Digital Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 65. Europe Digital Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 66. Europe Digital Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 67. Europe Digital Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 68. Europe Digital Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 69. Europe Digital Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 70. Europe Digital Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 71. Asia-Pacific Digital Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 72. Asia-Pacific Digital Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 73. Asia-Pacific Digital Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 74. Asia-Pacific Digital Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 75. Asia-Pacific Digital Therapeutics Consumption Value by Region (2019-2024) & (USD Million)
Table 76. Asia-Pacific Digital Therapeutics Consumption Value by Region (2025-2030) & (USD Million)
Table 77. South America Digital Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 78. South America Digital Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 79. South America Digital Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 80. South America Digital Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 81. South America Digital Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 82. South America Digital Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 83. Middle East & Africa Digital Therapeutics Consumption Value by Type (2019-2024) & (USD Million)
Table 84. Middle East & Africa Digital Therapeutics Consumption Value by Type (2025-2030) & (USD Million)
Table 85. Middle East & Africa Digital Therapeutics Consumption Value by Application (2019-2024) & (USD Million)
Table 86. Middle East & Africa Digital Therapeutics Consumption Value by Application (2025-2030) & (USD Million)
Table 87. Middle East & Africa Digital Therapeutics Consumption Value by Country (2019-2024) & (USD Million)
Table 88. Middle East & Africa Digital Therapeutics Consumption Value by Country (2025-2030) & (USD Million)
Table 89. Digital Therapeutics Raw Material
Table 90. Key Suppliers of Digital Therapeutics Raw Materials

List of Figures
Figure 1. Digital Therapeutics Picture
Figure 2. Global Digital Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Digital Therapeutics Consumption Value Market Share by Type in 2023
Figure 4. Software
Figure 5. Devices
Figure 6. Global Digital Therapeutics Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Digital Therapeutics Consumption Value Market Share by Application in 2023
Figure 8. Diabetes Picture
Figure 9. Obesity Picture
Figure 10. Cardio Vascular Diseases (CVD) Picture
Figure 11. Central Nervous System (CNS) Disease Picture
Figure 12. Gastrointestinal Disorders (GID) Picture
Figure 13. Respiratory Diseases Picture
Figure 14. Smoking Cessation Picture
Figure 15. Others Picture
Figure 16. Global Digital Therapeutics Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 17. Global Digital Therapeutics Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 18. Global Market Digital Therapeutics Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 19. Global Digital Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 20. Global Digital Therapeutics Consumption Value Market Share by Region in 2023
Figure 21. North America Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East and Africa Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Digital Therapeutics Revenue Share by Players in 2023
Figure 27. Digital Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 28. Global Top 3 Players Digital Therapeutics Market Share in 2023
Figure 29. Global Top 6 Players Digital Therapeutics Market Share in 2023
Figure 30. Global Digital Therapeutics Consumption Value Share by Type (2019-2024)
Figure 31. Global Digital Therapeutics Market Share Forecast by Type (2025-2030)
Figure 32. Global Digital Therapeutics Consumption Value Share by Application (2019-2024)
Figure 33. Global Digital Therapeutics Market Share Forecast by Application (2025-2030)
Figure 34. North America Digital Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 35. North America Digital Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 36. North America Digital Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 38. Canada Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 39. Mexico Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 40. Europe Digital Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 41. Europe Digital Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 42. Europe Digital Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 44. France Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 45. United Kingdom Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 46. Russia Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 47. Italy Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Digital Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Digital Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Digital Therapeutics Consumption Value Market Share by Region (2019-2030)
Figure 51. China Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 52. Japan Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 53. South Korea Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 54. India Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 55. Southeast Asia Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 56. Australia Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 57. South America Digital Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 58. South America Digital Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 59. South America Digital Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 60. Brazil Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 61. Argentina Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 62. Middle East and Africa Digital Therapeutics Consumption Value Market Share by Type (2019-2030)
Figure 63. Middle East and Africa Digital Therapeutics Consumption Value Market Share by Application (2019-2030)
Figure 64. Middle East and Africa Digital Therapeutics Consumption Value Market Share by Country (2019-2030)
Figure 65. Turkey Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 66. Saudi Arabia Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 67. UAE Digital Therapeutics Consumption Value (2019-2030) & (USD Million)
Figure 68. Digital Therapeutics Market Drivers
Figure 69. Digital Therapeutics Market Restraints
Figure 70. Digital Therapeutics Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Digital Therapeutics in 2023
Figure 73. Manufacturing Process Analysis of Digital Therapeutics
Figure 74. Digital Therapeutics Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source



★調査レポート[Global Digital Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030] (コード：GIR773KT3330)販売に関する免責事項を必ずご確認ください。
★調査レポート[Global Digital Therapeutics Market 2024 by Company, Regions, Type and Application, Forecast to 2030]についてメールでお問い合わせ
カテゴリー： 世界, 医療, Grand View Research
Grand View Researchが出版した調査資料（GVR-1-68038-768-1）・商品コード：GVR-1-68038-768-1
・発行会社（調査会社）：Grand View Research
・発行日：2024年8月
・ページ数：120
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD5,950 ⇒換算￥904,400見積依頼/購入/質問フォーム
Corporate License（法人閲覧用）USD8,950 ⇒換算￥1,360,400見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

世界のデジタル治療市場規模は2023年に62億米ドルと推定され、2024年から2030年にかけては年平均成長率（CAGR）27.2%で成長すると予測されています。市場成長の主な要因は、医療提供者および患者にとってのデジタルヘルス技術の費用対効果の高さと、先進国および発展途上国におけるスマートフォンの普及率上昇です。患者中心のケアと統合医療システムに対する需要の高まりが市場を牽引すると予想されています。また、償還政策の後押し、新型コロナウイルス感染症（COVID-19）のパンデミック、デジタルヘルスソリューションの普及率上昇、慢性疾患の発生率上昇も市場成長の追い風となることが期待されています。

❖ レポートの目次 ❖

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Application
1.1.2. End Use
1.1.3. Regional scope
1.1.4. Estimates and forecast timeline.
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database.
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Application outlook
2.2.2. End Use outlook
2.2.3. Regional outlook
2.3. Competitive Insights
Chapter 3. Digital Therapeutics Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Digital Therapeutics Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Digital Therapeutics Market: Application Estimates & Trend Analysis
4.1. Application Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Digital Therapeutics Market by Application Outlook
4.4. Diabetes
4.4.1. Market estimates and forecast 2018 – 2030 (USD Million)
4.5. Obesity
4.5.1. Market estimates and forecast 2018 – 2030 (USD Million)
4.6. Cardiovascular Disease (CVD)
4.6.1. Market estimates and forecast 2018 – 2030 (USD Million)
4.7. Respiratory Diseases
4.7.1. Market estimates and forecast 2018 – 2030 (USD Million)
4.8. Smoking Cessation
4.8.1. Market estimates and forecast 2018 – 2030 (USD Million)
4.9. Central Nervous System (CNS) Disease
4.9.1. Market estimates and forecast 2018 – 2030 (USD Million)
4.10. Others
4.10.1. Market estimates and forecast 2018 – 2030 (USD Million)
Chapter 5. Digital Therapeutics Market: End Use Estimates & Trend Analysis
5.1. End Use Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Digital Therapeutics Market by End Use Outlook
5.4. Patients
5.4.1. Market estimates and forecast 2018 – 2030 (USD Million)
5.5. Providers
5.5.1. Market estimates and forecast 2018 – 2030 (USD Million)
5.6. Payers
5.6.1. Market estimates and forecast 2018 – 2030 (USD Million)
5.7. Employers
5.7.1. Market estimates and forecast 2018 – 2030 (USD Million)
5.8. Others
5.8.1. Market estimates and forecast 2018 – 2030 (USD Million)
Chapter 6. Digital Therapeutics Market: Regional Estimates & Trend Analysis, By Application, By End Use
6.1. Regional Market Share Analysis, 2023 & 2030
6.2. Regional Market Dashboard
6.3. Global Regional Market Snapshot
6.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
6.5. North America
6.5.1. U.S.
6.5.1.1. Key country dynamics
6.5.1.2. Regulatory framework/ reimbursement structure
6.5.1.3. Competitive scenario
6.5.1.4. U.S. market estimates and forecasts 2018 – 2030 (USD Million)
6.5.2. Canada
6.5.2.1. Key country dynamics
6.5.2.2. Regulatory framework/ reimbursement structure
6.5.2.3. Competitive scenario
6.5.2.4. Canada market estimates and forecasts 2018 – 2030 (USD Million)
6.5.3. Mexico
6.5.3.1. Key country dynamics
6.5.3.2. Regulatory framework/ reimbursement structure
6.5.3.3. Competitive scenario
6.5.3.4. Mexico market estimates and forecasts 2018 – 2030 (USD Million)
6.6. Europe
6.6.1. UK
6.6.1.1. Key country dynamics
6.6.1.2. Regulatory framework/ reimbursement structure
6.6.1.3. Competitive scenario
6.6.1.4. UK market estimates and forecasts 2018 – 2030 (USD Million)
6.6.2. Germany
6.6.2.1. Key country dynamics
6.6.2.2. Regulatory framework/ reimbursement structure
6.6.2.3. Competitive scenario
6.6.2.4. Germany market estimates and forecasts 2018 – 2030 (USD Million)
6.6.3. France
6.6.3.1. Key country dynamics
6.6.3.2. Regulatory framework/ reimbursement structure
6.6.3.3. Competitive scenario
6.6.3.4. France market estimates and forecasts 2018 – 2030 (USD Million)
6.6.4. Italy
6.6.4.1. Key country dynamics
6.6.4.2. Regulatory framework/ reimbursement structure
6.6.4.3. Competitive scenario
6.6.4.4. Italy market estimates and forecasts 2018 – 2030 (USD Million)
6.6.5. Spain
6.6.5.1. Key country dynamics
6.6.5.2. Regulatory framework/ reimbursement structure
6.6.5.3. Competitive scenario
6.6.5.4. Spain market estimates and forecasts 2018 – 2030 (USD Million)
6.6.6. Denmark
6.6.6.1. Key country dynamics
6.6.6.2. Regulatory framework/ reimbursement structure
6.6.6.3. Competitive scenario
6.6.6.4. Denmark market estimates and forecasts 2018 – 2030 (USD Million)
6.6.7. Sweden
6.6.7.1. Key country dynamics
6.6.7.2. Regulatory framework/ reimbursement structure
6.6.7.3. Competitive scenario
6.6.7.4. Sweden market estimates and forecasts 2018 – 2030 (USD Million)
6.6.8. Norway
6.6.8.1. Key country dynamics
6.6.8.2. Regulatory framework/ reimbursement structure
6.6.8.3. Competitive scenario
6.6.8.4. Norway market estimates and forecasts 2018 – 2030 (USD Million)
6.7. Asia Pacific
6.7.1. Japan
6.7.1.1. Key country dynamics
6.7.1.2. Regulatory framework/ reimbursement structure
6.7.1.3. Competitive scenario
6.7.1.4. Japan market estimates and forecasts 2018 – 2030 (USD Million)
6.7.2. China
6.7.2.1. Key country dynamics
6.7.2.2. Regulatory framework/ reimbursement structure
6.7.2.3. Competitive scenario
6.7.2.4. China market estimates and forecasts 2018 – 2030 (USD Million)
6.7.3. India
6.7.3.1. Key country dynamics
6.7.3.2. Regulatory framework/ reimbursement structure
6.7.3.3. Competitive scenario
6.7.3.4. India market estimates and forecasts 2018 – 2030 (USD Million)
6.7.4. Australia
6.7.4.1. Key country dynamics
6.7.4.2. Regulatory framework/ reimbursement structure
6.7.4.3. Competitive scenario
6.7.4.4. Australia market estimates and forecasts 2018 – 2030 (USD Million)
6.7.5. South Korea
6.7.5.1. Key country dynamics
6.7.5.2. Regulatory framework/ reimbursement structure
6.7.5.3. Competitive scenario
6.7.5.4. South Korea market estimates and forecasts 2018 – 2030 (USD Million)
6.7.6. Thailand
6.7.6.1. Key country dynamics
6.7.6.2. Regulatory framework/ reimbursement structure
6.7.6.3. Competitive scenario
6.7.6.4. Thailand market estimates and forecasts 2018 – 2030 (USD Million)
6.8. Latin America
6.8.1. Brazil
6.8.1.1. Key country dynamics
6.8.1.2. Regulatory framework/ reimbursement structure
6.8.1.3. Competitive scenario
6.8.1.4. Brazil market estimates and forecasts 2018 – 2030 (USD Million)
6.8.2. Argentina
6.8.2.1. Key country dynamics
6.8.2.2. Regulatory framework/ reimbursement structure
6.8.2.3. Competitive scenario
6.8.2.4. Argentina market estimates and forecasts 2018 – 2030 (USD Million)
6.9. MEA
6.9.1. South Africa
6.9.1.1. Key country dynamics
6.9.1.2. Regulatory framework/ reimbursement structure
6.9.1.3. Competitive scenario
6.9.1.4. South Africa market estimates and forecasts 2018 – 2030 (USD Million)
6.9.2. Saudi Arabia
6.9.2.1. Key country dynamics
6.9.2.2. Regulatory framework/ reimbursement structure
6.9.2.3. Competitive scenario
6.9.2.4. Saudi Arabia market estimates and forecasts 2018 – 2030 (USD Million)
6.9.3. UAE
6.9.3.1. Key country dynamics
6.9.3.2. Regulatory framework/ reimbursement structure
6.9.3.3. Competitive scenario
6.9.3.4. UAE market estimates and forecasts 2018 – 2030 (USD Million)
6.9.4. Kuwait
6.9.4.1. Key country dynamics
6.9.4.2. Regulatory framework/ reimbursement structure
6.9.4.3. Competitive scenario
6.9.4.4. Kuwait market estimates and forecasts 2018 – 2030 (USD Million)
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Company Profiles
7.3.1. OMADA HEALTH, INC.
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Product benchmarking
7.3.1.4. Strategic initiatives
7.3.2. Welldoc, Inc.
7.3.2.1. Company overview
7.3.2.2. Financial performance
7.3.2.3. Product benchmarking
7.3.2.4. Strategic initiatives
7.3.3. 2Morrow, Inc
7.3.3.1. Company overview
7.3.3.2. Financial performance
7.3.3.3. Product benchmarking
7.3.3.4. Strategic initiatives
7.3.4. Livongo Health, Inc. (Teladoc Health, Inc.)
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Product benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Propeller Health (ResMed)
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Product benchmarking
7.3.5.4. Strategic initiatives
7.3.6. Fitbit LLC
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Product benchmarking
7.3.6.4. Strategic initiatives
7.3.7. Mango Health
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Product benchmarking
7.3.7.4. Strategic initiatives
7.3.8. CANARY HEALTH
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Product benchmarking
7.3.8.4. Strategic initiatives
7.3.9. Noom, Inc.
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Product benchmarking
7.3.9.4. Strategic initiatives
7.3.10. Pear Therapeutics, Inc.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Product benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Akili Interactive Labs, Inc.
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Product benchmarking
7.3.11.4. Strategic initiatives
7.3.12. HYGIEIA
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Product benchmarking
7.3.12.4. Strategic initiatives
7.3.13. DarioHealth Corp.
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Product benchmarking
7.3.13.4. Strategic initiatives
7.3.14. BigHealth
7.3.14.1. Company overview
7.3.14.2. Financial performance
7.3.14.3. Product benchmarking
7.3.14.4. Strategic initiatives
7.3.15. GAIA AG
7.3.15.1. Company overview
7.3.15.2. Financial performance
7.3.15.3. Product benchmarking
7.3.15.4. Strategic initiatives
7.3.16. Limbix Health, Inc.
7.3.16.1. Company overview
7.3.16.2. Financial performance
7.3.16.3. Product benchmarking
7.3.16.4. Strategic initiatives

 

Digital Therapeutics Market Size & Trends

The global digital therapeutics market size was estimated at USD 6.2 billion in 2023 and is expected to grow at a CAGR of 27.2% from 2024 to 2030. Market growth is primarily driven by the cost-effectiveness of digital health technology for providers & patients and rising smartphone penetration in developed & developing countries. Increasing demand for patient-centric care & integrated healthcare systems are expected to drive the market. Supportive reimbursement policies, the COVID-19 pandemic, increasing adoption of digital health solutions, and the rising incidence of chronic diseases are also expected to fuel the market growth.Digital Therapeutics Market Size by Application, 2020 - 2030 (USD Billion)To learn more about this report, request a free sample copy

The rise in internet penetration across the globe has had a positive impact on the market. According to the GSM Association (GSMA) statistics published in the Mobile Economy 2024 report, around 5.6 billion people across the globe subscribed to mobile services in 2023, and the number of unique mobile subscribers is expected to reach 6.3 billion by 2030. For instance, as per the Mobile Economy 2023 report, smartphone penetration was around 76% in 2022 and is expected to reach 92% by 2030. As this number grows, the awareness and adoption of intelligent health monitoring is anticipated to improve.

Key mobile industry milestones to 2030To learn more about this report, request a free sample copy

Continuous improvements in network infrastructure and coverage are expected to improve the demand for digital therapeutics. Mobile network operators perceive digital health and digital therapeutics as investment opportunities due to the increasing smartphone adoption. As per a report published by GSMA in 2023, the global penetration of 5G is estimated to be 54% by 2030. In addition, the increased bandwidth and the low latency of 5G are anticipated to facilitate the sharing of images & videos with higher resolution, increasing the quality & value of virtual interaction. This will help reduce the need to visit a hospital or clinic and benefit remote patients who may not have easy access to a medical facility or hospital.

The COVID-19 pandemic notably propelled the rate of change in digital therapeutics by accelerating regulatory flexibility, thus expanding access to digital health products and fueling patient demand. The pandemic has increased demand for accessible and convenient digital health solutions. For instance, the guidelines released by the FDA in April 2020 stated that for the duration of the pandemic, it would enable the use and distribution of digital health therapeutic devices for psychiatric disorders. Thus, vendors can commercialize their solutions without complying with usual regulatory requirements, provided the devices do not create any undue public health emergency.

The increasing incidence of chronic diseases significantly contributes to the market’s growth. As per CDC’s National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 American adults suffer from a chronic disease, while 4 out of 10 adults have two or more chronic diseases. For instance, in January 2024, Amazon Health initiated a new Health Condition Programs program targeting chronic health issues. This new effort allows consumers to explore digital health advantages aimed at managing chronic diseases, including diabetes and hypertension. Moreover, chronic lung disease, cancer, Alzheimer’s disease, diabetes, cardiovascular diseases, and chronic kidney disease have been identified as leading causes of death and disability in the country.

The regulatory landscape for digital therapeutics is becoming favorable, with increasing recognition of their potential benefits. This is encouraging more investment and development in digital therapeutics (DTx) and making it easier for companies to bring their products to market. There is a growing movement towards value-based care, which emphasizes the quality and effectiveness of care over the quantity of services provided. Digital therapeutics products are suited to value-based care models, as they can be shown to improve patient outcomes and reduce healthcare costs.

Recent regulatory changes, such as the FDA’s establishment of the Digital Health Center of Excellence and new reimbursement codes for remote therapeutic monitoring (RTM), further support the adoption of DTx. Remote therapeutic monitoring codes (98975, 98976, 98977, 98980, and 98981) specify initial setup, education, and device provision, plus two codes for clinician time spent on RTM treatment. These codes support clinical staff in performing RTM remotely, aligning with existing remote and chronic care policies.

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:
  • Competitive benchmarking
  • Historical data & forecasts
  • Company revenue shares
  • Regional opportunities
  • Latest trends & dynamics

View Data On Platform

The Grand Library - BI Enabled Market Research DatabaseExplore Sample Data

Market Concentration & Characteristics

The market is marked by a high degree of innovation. According to recent data, as of April 2024, there are 739 digital therapeutics devices in various stages of development worldwide, with 649 actively being developed. This includes 390 products in the early stages and 259 in the later stages. Key players in this market include companies such as Alex Therapeutics, Pear Therapeutics, and Click Therapeutics, among others, which are innovating and launching products. For instance, in November 2023, AstraZeneca launched Evinova, a new health technology division to drive innovation throughout the life sciences industry. This division will focus on enhancing the conduction of clinical trials and improving health results.

In recent years, both the U.S. and Europe have taken significant regulatory steps to promote the development of digital health technologies, impacting the market. For instance, in the U.S., the FDA’s 2017 Digital Health Innovation Action Plan, part of the 21st Century Cures Act, introduced a precertification program allowing low-risk digital health software to be marketed with minimal oversight and reclassified certain medical software to be no longer regulated as medical devices. Key U.S. laws include HIPAA, the FD&C Act, the FTC Act, and the FTC’s Health Breach Notification Rule, ensuring privacy, data security, and safe app performance.

Digital Therapeutics Industry DynamicsTo learn more about this report, request a free sample copy

The market is witnessing a high level of mergers and acquisitions (M&A) activity. Major healthcare and technology companies are acquiring smaller, innovative firms to enhance their product portfolios and leverage advanced technologies. For instance, in May 2024, digital therapeutics company Akili, known for its video game treatment for ADHD, will be acquired for USD 34 million. Akili is set to merge with Virtual Therapeutics to form a larger digital health organization.

Product expansion in the market involves introducing new & advanced products and solutions to expand the company’s position in the market. For instance, in October 2023, Better Therapeutics, Inc., a prescription digital therapeutics (PDT) for cardio-metabolic diseases, announced the launch of AspyreRx. This is the cognitive behavioral therapy app authorized by the U.S. Food and Drug Administration as a Class II device for treating adults with type 2 diabetes.

Application Insights

The diabetes segment dominated the market with the largest market share of 29.36% in 2023 and is expected to register the fastest CAGR over the forecast period. Factors driving the segment growth include the growing prevalence of diabetes and other related chronic diseases. According to a 2023 report by the Institute for Health Metrics and Evaluation, over half a billion people globally are living with diabetes, impacting men, women, and children of all ages in every country.

Obesity held the second-largest market share due to the growing obesity rate globally. Digital therapeutics provide cost-effective solutions for treating many chronic diseases, which is expected to fuel the segment’s growth in the near future. CVDs and smoking cessation, along with obesity, are expected to demonstrate significant growth rates during the forecast period.

End Use Insights

The patient segment holds the largest market share of 34.08% in 2023 and is anticipated to register the fastest growth rate over the forecast period, owing to patients’ rapid adoption of digital therapeutics. Patients are provided with care programs that are personalized and based on scientific evidence. Digital therapeutics also improve access to care for people, especially those from rural and remote areas. It can help providers monitor patients in real time, identify the gap in care, and provide timely interventions. It improves the efficiency of care delivery through evidence-based care therapies. This solution can reduce the need for physicians to intervene frequently in managing people with chronic conditions.

Digital Therapeutics Market Share by End Use, 2023 (%)To learn more about this report, request a free sample copy

On the other hand, the provider’s segment holds the second-largest market share. The growth of the providers’ end use segment can be attributed to more providers leveraging digital therapeutics to support and deliver medically proven therapies outside of a care setting and provide reliable patient engagement. Payers are increasingly interested in covering digital therapeutics, which shows a significant growth scope. Also, they are encouraged to undertake initiatives by business models that facilitate adherence and enhance efficacy while reducing costs.

Regional Insights

North America dominated the market with a revenue share of 40.43% in 2023. The overall market in the region is expected to grow significantly over the forecast period owing to the increased use of digital health products and favorable reimbursement scenarios that focus on improving quality of life through improved tracking & diagnostics. Factors such as rapid growth in the adoption of smartphones, advancements in coverage networks, acute shortage of primary caregivers, and rise in prevalence of chronic diseases, geriatric population, costs of healthcare, & need for improved prevention & management of chronic conditions are driving the growth of digital therapeutics in North America.

U.S. Digital Therapeutics Market Trends

The digital therapeutics market in the U.S. held a majority of revenue share of over 85% in the North American region. The continuously changing digital landscape, rising consumerism in healthcare, the COVID-19 pandemic, and initiatives by key companies, including mergers, acquisitions, funding, etc., are key factors fueling market growth. For instance, in October 2021, Click Therapeutics, Inc. received USD 52 million in Series B funding from multiple investors. This enabled the development and commercialization of the company’s prescription digital therapeutic pipeline while also helping it advance its platform capabilities. 

Europe Digital Therapeutics Market Trends

The digital therapeutics market in Europe is expected to gain momentum over the forecast period due to healthcare providers’ and patients growing adoption of apps. The presence of developed economies, such as Germany, the UK, France, Spain, & Italy, is expected to fuel the market in Europe during the forecast period. The EC’s Digital Single Market Strategy can give consumers and businesses access to online services & goods across Europe, providing necessary conditions for the growth of the digital network & allied services, which is expected to help maximize the growth potential of the European economy.

The UK digital therapeutics market is experiencing rapid growth, driven by increasing demand for evidence-based solutions to manage chronic diseases such as diabetes, mental health disorders, and cardiovascular issues. Factors contributing to this expansion include the rising prevalence of chronic conditions, heightened awareness of proactive healthcare management, and the convenience offered by digital solutions. The market encompasses a variety of products that can be utilized independently or alongside traditional therapies, emphasizing the importance of clinical validation and user-friendly design. In addition, the growing penetration of smartphones and healthcare applications supports the adoption of digital therapeutics among consumers, marking a significant shift towards integrated and patient-centered care in the UK healthcare landscape.

Digital Therapeutics Market Trends, by Region, 2024 - 2030To learn more about this report, request a free sample copy

The digital therapeutics market in Germany is anticipated to grow due to its well-established healthcare infrastructure, availability of technologically advanced & connected medical devices, and easy access to patient health information. Moreover, the increasing incidence of lifestyle-associated disorders creates a demand for personal health monitoring devices, which is anticipated to boost the market over the forecast period. Furthermore, initiatives by government and private players in the country are also driving the market’s growth. For instance, introducing the Digital Healthcare Act in 2019 established the Digital Health Applications (DiGA) program, which provides a streamlined pathway for evaluating, listing, and reimbursing DTx products.

Asia Pacific Digital Therapeutics Market Trends

The digital therapeutics market in Asia Pacific is anticipated to witness substantial growth, with the fastest CAGR over the forecast period, due to increased government spending on healthcare and high demand for IT services. The demand for healthcare IT systems has been growing as they enable efficient management of hospitals’ clinical, financial, and administrative aspects. An increase in demand for adequate healthcare, improved access to the internet, and a rise in smartphone penetration are the factors facilitating a rapid increase in the Asia Pacific market.

Japan digital therapeutics market is expected to grow over the forecast period, owing to the advancing digital infrastructure and the growing senior population. In addition, the Ministry of Health, Labor & Welfare launched several initiatives to improve existing healthcare infrastructure. In April 2021, Jolly Good, Inc. established a specialized DTx Division to develop digital therapeutics using VR and AI technologies. The company planned a corporate expansion of digital therapeutics worldwide.

The digital therapeutics market in China is experiencing rapid growth, driven by increasing chronic disease prevalence and strong government support for digital health initiatives. Key players in the market include Alibaba Health, WeDoctor, and Omada Health, which are leveraging digital technologies to provide evidence-based therapeutic interventions through software and mobile applications. Technological advancements and the growing acceptance of digital health solutions among consumers further fuel the market’s expansion. For instance, in February 2023, NERVTEX, a company based in China that specializes in digital therapy solutions for neurological conditions, received authorization from the China National Medical Products Administration for its artificial intelligence-driven software designed to analyze movement disorders.

Latin America Digital Therapeutics Market Trends

The digital therapeutics market in Latin America is expected to grow owing to rapid technological advancements and increasing digitalization. This can be attributed to various factors, such as increased healthcare awareness and the availability of technically advanced procedures for diagnosing and treating critical diseases. The increasing internet penetration has also led to the growing use of e-prescribing systems in the region. Furthermore, regional governments are boosting their investment, while local and global private sector firms are investing significantly in the area to improve their footprint.

Brazil digital therapeutics market is witnessing significant growth, driven by an increased awareness of the benefits of digital health solutions among both healthcare providers and patients. This market’s expansion is further fueled by supportive government policies to integrate digital solutions into the national healthcare system and growing investment in health tech startups. As access to smartphones and internet connectivity continues to increase across the country, digital therapeutics are becoming increasingly accessible, thereby driving growth in the country.

Middle East & Africa Digital Therapeutics Market Trends

The digital therapeutics market in MEA is expected to increase due to the growing smartphone use in this region. This is expected to facilitate adopting connected health services in the MEA, resulting in market growth. Advancements in healthcare are expected to boost the adoption of digital health solutions, including digital therapeutics. Growing internet usage in the healthcare sector facilitates various healthcare practices, equipment functions, patient database maintenance, etc., which is expected to drive market growth.

South Africa digital therapeutics market is growing at a slower pace, majorly due to a need for established healthcare infrastructure and limited awareness regarding technological advancements. Although the South African market is in the nascent stage, an increase in the adoption of advanced technologies in healthcare is expected to boost the market. For instance, The National Digital Health Strategy for South Africa, from 2019 to 2024, aims to strengthen governance in the digital health sector, establish strong integrated platforms to advance information system development, and build the necessary infrastructure in collaboration with various government departments.

Key Digital Therapeutics Company Insights

The global market is highly competitive and dominated by a few renowned companies. Participants are adopting various strategies, such as mergers, partnerships, collaborations, and acquisitions, to enhance their marketplace presence.

Key Digital Therapeutics Companies:

The following are the leading companies in the digital therapeutics market. These companies collectively hold the largest market share and dictate industry trends.

  • OMADA HEALTH, INC.
  • Welldoc, Inc.
  • 2Morrow, Inc
  • Livongo Health, Inc. (Teladoc Health, Inc.)
  • Propeller Health (ResMed)
  • Fitbit LLC
  • Mango Health
  • CANARY HEALTH
  • Noom, Inc.
  • Pear Therapeutics, Inc.
  • Akili Interactive Labs, Inc.
  • HYGIEIA
  • DarioHealth Corp.
  • BigHealth
  • GAIA AG
  • Limbix Health, Inc.

Recent Developments

  • In May 2024, Otsuka announced the launch of a subsidiary focused on data and technology. This entity, named Otsuka Precision Health, will commercialize Rejoyn, a digital therapeutic specifically designed for individuals suffering from major depressive disorder.
  • In January 2024, Eli Lilly and Company announced the launch of LillyDirect, a digital healthcare platform for U.S. patients managing obesity, migraine, and diabetes. LillyDirect provides a suite of disease management tools, enabling personalized support, access to independent healthcare providers, and the convenience of direct delivery of certain Lilly medications to homes through third-party pharmacy services.
  • In November 2023, Curavit Clinical Research, a virtual contract research organization, introduced a new service for clinical trials focused on Health Economics and Outcomes Research (HEOR). This latest inclusion in clinical trials aims to give pharmaceutical companies a deeper understanding of their product’s value and potential in the market.
  • In July 2023, Big Health, known for its non-pharmacological digital mental health solutions, announced the acquisition of Limbix, a company specializing in digital therapeutics for adolescents and young adults experiencing depressive symptoms. This acquisition allows Big Health to broaden its array of therapeutic offerings, adding SparkRx, aimed at treating depression in adolescents, and a product under development for adolescent anxiety to its established programs. These flagship programs include Sleepio, designed to combat insomnia, and Daylight, to alleviate anxiety, catering to individuals 18 years and older.


★調査レポート[Digital Therapeutics Market Size, Share & Trends Analysis Report By Application (Diabetes, Obesity), By End Use (Patients, Providers, Payers, Employers), By Region, And Segment Forecasts, 2024 – 2030] (コード：GVR-1-68038-768-1)販売に関する免責事項を必ずご確認ください。
★調査レポート[Digital Therapeutics Market Size, Share & Trends Analysis Report By Application (Diabetes, Obesity), By End Use (Patients, Providers, Payers, Employers), By Region, And Segment Forecasts, 2024 – 2030]についてメールでお問い合わせ
カテゴリー： 世界, 医療, MarketsandMarkets
MarketsandMarketsが出版した調査資料（HIT 4407）・商品コード：HIT 4407
・発行会社（調査会社）：MarketsandMarkets
・発行日：2024年1月
・ページ数：290
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,950 ⇒換算￥752,400見積依頼/購入/質問フォーム
Corporate License（法人閲覧用）USD8,150 ⇒換算￥1,238,800見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

2022年に44億米ドルの規模であった世界のデジタルセラピー市場は、2023年には61億米ドル、2028年には219億米ドルに達し、29.1%という堅調なCAGRで成長すると予測されています。デジタル治療薬の急速な普及は、慢性疾患の増加、ベンチャーキャピタルからの投資の急増、テクノロジー企業と医療提供者の戦略的提携によって促進されています。成長を促進する最も重要な要因の1つは、AI/ML、ウェアラブル、モバイルなどの高度なデジタル技術の統合です。例えば、2022年にMobile Health (US)は、エビデンスに基づく治療介入をAIベースのコミュニケーションで提供する、完全に統合されたデジタル治療（DTx）ソリューションスイートを発売しました。しかし、明確な規制ガイドラインの欠如や償還プロセスが遅いこと、さらに開発、維持、アップグレードに多額の費用がかかることが、市場でのデジタル治療ソリューションの採用を妨げる要因となっています。

❖ レポートの目次 ❖

  • INTRODUCTION
    • STUDY OBJECTIVES
    • MARKET DEFINITION
    • INCLUSIONS AND EXCLUSIONS
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED
      • CURRENCY CONSIDERED
    • STAKEHOLDERS
    • RESEARCH LIMITATIONS
    • SUMMARY OF CHANGES
    • RECESSION IMPACT
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION
      • BOTTOM-UP APPROACH
      • TOP-DOWN APPROACH: PENETRATION RATE-BASED MARKET SIZE ESTIMATION
      • GROWTH FORECAST
        • Table IMPACT ANALYSIS
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • ASSUMPTIONS
    • RISK ASSESSMENT
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • DIGITAL THERAPEUTICS MARKET OVERVIEW
    • DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2023 VS. 2O28
    • DIGITAL THERAPEUTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
      • OPPORTUNITIES
      • CHALLENGES
    • INDUSTRY TRENDS
      • VIRTUAL REALITY
      • RISING DEMAND FOR DIGITAL SOLUTIONS IN CBT
    • TECHNOLOGY ANALYSIS
      • Table TECHNOLOGY ENABLERS, BENEFITS, AND EXAMPLES
      • MACHINE LEARNING
      • ARTIFICIAL INTELLIGENCE
      • INTERNET OF THINGS
      • BLOCKCHAIN TECHNOLOGY
      • CLOUD COMPUTING
      • DATA ANALYTICS
      • EXTENDED REALITY
    • VALUE CHAIN ANALYSIS
      • RESEARCH & PRODUCT DEVELOPMENT
      • MATERIAL COMPONENTS
      • MANUFACTURERS & DEVELOPERS
      • DISTRIBUTION & SALES
      • END-USER INDUSTRIES
      • POST-SALE SERVICES
    • ECOSYSTEM ANALYSIS
    • PIPELINE PRODUCTS
    • CASE STUDY ANALYSIS
      • CASE STUDY 1: WELLTHY THERAPEUTICS (INDIA)
      • CASE STUDY 2: HAPPIFY HEALTH (US)
      • CASE STUDY 3: OMADA HEALTH (US)
    • PORTER’S FIVE FORCES ANALYSIS
      • THREAT OF NEW ENTRANTS
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • THREAT OF SUBSTITUTES
      • INTENSITY OF COMPETITIVE RIVALRY
    • REGULATORY LANDSCAPE
      • REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
        • Table NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
        • Table EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
        • Table ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
        • Table REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
        • Table DIGITAL THERAPEUTICS MARKET: REGULATORY DATA NEEDED FOR CLASS II DEVICES
    • PRICING ANALYSIS
      • COSTS INVOLVED IN DIGITAL THERAPEUTICS
      • INDICATIVE PRICING ANALYSIS, BY KEY PLAYER & COUNTRY
        • Table AVERAGE SELLING PRICE OF DIGITAL THERAPEUTIC PRODUCTS, BY COUNTRY
      • INDICATIVE PRICING ANALYSIS OF DIGITAL THERAPEUTICS, BY REGION
    • REIMBURSEMENT SCENARIO
      • Table DIGITAL THERAPEUTICS MARKET: GLOBAL COVERAGE DETERMINATION STANDARDS
    • PATENT ANALYSIS
      • PATENT PUBLICATION TRENDS
      • INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
      • LIST OF MAJOR PATENTS
        • Table KEY PATENTS IN DIGITAL THERAPEUTICS MARKET
    • KEY CONFERENCES AND EVENTS
      • Table DIGITAL THERAPEUTICS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2023-2024)
    • KEY STAKEHOLDERS AND BUYING CRITERIA
      • KEY STAKEHOLDERS IN BUYING PROCESS
        • Table INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR SALES CHANNEL, BY RANKING
      • BUYING CRITERIA
        • Table KEY BUYING CRITERIA FOR SALES CHANNEL, BY RANKING
    • REVENUE SHIFT AND NEW REVENUE POCKETS FOR DIGITAL THERAPEUTICS MARKET
    • INVESTMENT LANDSCAPE
  • DIGITAL THERAPEUTICS MARKET, BY OFFERING
    • INTRODUCTION
      • Table DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
    • SOFTWARE/PLATFORMS
      • ABILITY TO PROVIDE SCALABLE SOLUTIONS FOR DEPLOYMENT TO PROPEL MARKET
        • Table DIGITAL THERAPEUTICS MARKET FOR SOFTWARE/PLATFORMS, BY REGION, 2021-2028 (USD MILLION)
    • PROGRAMS
      • INTRODUCTION OF EVIDENCE-BASED THERAPEUTIC PROGRAMS TO SUPPORT MARKET GROWTH
        • Table DIGITAL THERAPEUTICS MARKET FOR PROGRAMS, BY REGION, 2021-2028 (USD MILLION)
    • VIRTUAL REALITY/GAMES
      • RISING DEMAND FOR VR SOLUTIONS TO DRIVE MARKET
        • Table DIGITAL THERAPEUTICS MARKET FOR VIRTUAL REALITY/GAMES, BY REGION, 2021-2028 (USD MILLION)
  • DIGITAL THERAPEUTICS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TREATMENT/CARE-RELATED APPLICATIONS
      • Table DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
      • Table DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
      • DIABETES
        • Table DIGITAL THERAPEUTICS MARKET FOR DIABETES, BY REGION, 2021-2028 (USD MILLION)
      • CENTRAL NERVOUS SYSTEM (CNS) DISORDERS
        • Table DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY REGION, 2021-2028 (USD MILLION)
        • Table DIGITAL THERAPEUTICS MARKET FOR MENTAL HEALTH DISORDERS, BY REGION, 2021-2028 (USD MILLION)
        • Table DIGITAL THERAPEUTICS MARKET FOR OTHER CNS DISORDERS, BY REGION, 2021-2028 (USD MILLION)
      • SMOKING CESSATION
        • Table DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY REGION, 2021-2028 (USD MILLION)
      • CHRONIC RESPIRATORY DISEASES
        • Table DIGITAL THERAPEUTICS MARKET FOR CHRONIC RESPIRATORY DISEASES, BY REGION, 2021-2028 (USD MILLION)
      • MUSCULOSKELETAL DISORDERS
        • Table DIGITAL THERAPEUTICS MARKET FOR MUSCULOSKELETAL DISORDERS, BY REGION, 2021-2028 (USD MILLION)
      • CARDIOVASCULAR DISEASES
        • Table DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021-2028 (USD MILLION)
      • MEDICATION ADHERENCE
        • Table DIGITAL THERAPEUTICS MARKET FOR MEDICATION ADHERENCE, BY REGION, 2021-2028 (USD MILLION)
      • GASTROINTESTINAL DISORDERS
        • Table DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDERS, BY REGION, 2021-2028 (USD MILLION)
      • REHABILITATION & PATIENT CARE
        • Table DIGITAL THERAPEUTICS MARKET FOR REHABILITATION & PATIENT CARE, BY REGION, 2021-2028 (USD MILLION)
      • SUBSTANCE USE DISORDERS & ADDICTION MANAGEMENT
        • Table DIGITAL THERAPEUTICS MARKET FOR SUBSTANCE USE DISORDERS & ADDICTION MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
      • OTHER TREATMENT/CARE-RELATED APPLICATIONS
        • Table DIGITAL THERAPEUTICS MARKET FOR OTHER TREATMENT/CARE-RELATED APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
    • PREVENTIVE APPLICATIONS
      • Table DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
      • Table DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
      • PREDIABETES
        • Table DIGITAL THERAPEUTICS MARKET FOR PREDIABETES, BY REGION, 2021-2028 (USD MILLION)
      • OBESITY
        • Table DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY REGION, 2021-2028 (USD MILLION)
      • NUTRITION
        • Table DIGITAL THERAPEUTICS MARKET FOR NUTRITION, BY REGION, 2021-2028 (USD MILLION)
      • LIFESTYLE MANAGEMENT
        • Table DIGITAL THERAPEUTICS MARKET FOR LIFESTYLE MANAGEMENT, BY REGION, 2021-2028 (USD MILLION)
      • OTHER PREVENTIVE APPLICATIONS
        • Table DIGITAL THERAPEUTICS MARKET FOR OTHER PREVENTIVE APPLICATIONS, BY REGION, 2021-2028 (USD MILLION)
  • DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL
    • INTRODUCTION
      • Table DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
    • SUBSCRIPTION-BASED MODEL
      • FLEXIBILITY IN PAYMENT OPTIONS TO DRIVE MARKET
        • Table DIGITAL THERAPEUTICS MARKET FOR SUBSCRIPTION-BASED MODEL, BY REGION, 2021-2028 (USD MILLION)
    • ONE-TIME PURCHASE/ANNUAL LICENSING MODEL
      • BENEFITS OF LIMITED RECURRING PAYMENTS TO BOOST DEMAND
        • Table DIGITAL THERAPEUTICS MARKET FOR ONE-TIME PURCHASE/ANNUAL LICENSING MODEL, BY REGION, 2021-2028 (USD MILLION)
    • OUTCOME /VALUE-BASED MODEL
      • RESULT-DRIVEN APPROACH THAT ENHANCES END-USER ENGAGEMENT TO PROPEL MARKET
        • Table DIGITAL THERAPEUTICS MARKET FOR OUTCOME/VALUE-BASED MODEL, BY REGION, 2021-2028 (USD MILLION)
  • DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL
    • INTRODUCTION
      • Table DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
    • B2B SALES CHANNEL
      • Table DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • Table DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY REGION, 2021-2028 (USD MILLION)
      • PAYERS
        • Table DIGITAL THERAPEUTICS MARKET FOR PAYERS, BY REGION, 2021-2028 (USD MILLION)
      • EMPLOYERS
        • Table DIGITAL THERAPEUTICS MARKET FOR EMPLOYERS, BY REGION, 2021-2028 (USD MILLION)
      • PHARMACEUTICAL COMPANIES
        • Table DIGITAL THERAPEUTICS MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2021-2028 (USD MILLION)
      • PROVIDERS
        • Table DIGITAL THERAPEUTICS MARKET FOR PROVIDERS, BY REGION, 2021-2028 (USD MILLION)
      • OTHER BUYERS
        • Table DIGITAL THERAPEUTICS MARKET FOR OTHER BUYERS, BY REGION, 2021-2028 (USD MILLION)
    • B2C SALES CHANNEL
      • Table DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • Table DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY REGION, 2021-2028 (USD MILLION)
      • CAREGIVERS
        • Table DIGITAL THERAPEUTICS MARKET FOR CAREGIVERS, BY REGION, 2021-2028 (USD MILLION)
      • PATIENTS
        • Table DIGITAL THERAPEUTICS MARKET FOR PATIENTS, BY REGION, 2021-2028 (USD MILLION)
  • DIGITAL THERAPEUTICS MARKET, BY REGION
    • INTRODUCTION
      • Table DIGITAL THERAPEUTICS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • NORTH AMERICA
      • Table NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • Table NORTH AMERICA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • NORTH AMERICA: RECESSION IMPACT
      • US
        • Table US: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
        • Table US: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
        • Table US: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table US: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
        • Table US: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
        • Table US: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • CANADA
        • Table CANADA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
        • Table CANADA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
        • Table CANADA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table CANADA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
        • Table CANADA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
        • Table CANADA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
    • EUROPE
      • Table EUROPE: DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table EUROPE: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
      • Table EUROPE: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
      • Table EUROPE: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • Table EUROPE: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
      • Table EUROPE: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
      • Table EUROPE: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
      • Table EUROPE: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
      • Table EUROPE: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • Table EUROPE: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • EUROPE: RECESSION IMPACT
      • GERMANY
        • Table GERMANY: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
        • Table GERMANY: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
        • Table GERMANY: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table GERMANY: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
        • Table GERMANY: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
        • Table GERMANY: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • UK
        • Table UK: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
        • Table UK: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
        • Table UK: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table UK: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
        • Table UK: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
        • Table UK: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • FRANCE
        • Table FRANCE: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
        • Table FRANCE: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
        • Table FRANCE: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table FRANCE: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
        • Table FRANCE: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
        • Table FRANCE: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • SPAIN
        • Table SPAIN: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
        • Table SPAIN: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
        • Table SPAIN: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table SPAIN: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
        • Table SPAIN: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
        • Table SPAIN: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • ITALY
        • Table ITALY: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
        • Table ITALY: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
        • Table ITALY: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table ITALY: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
        • Table ITALY: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
        • Table ITALY: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • REST OF EUROPE
        • Table REST OF EUROPE: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
    • ASIA PACIFIC
      • Table ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • Table ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • ASIA PACIFIC: RECESSION IMPACT
      • JAPAN
        • Table JAPAN: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
        • Table JAPAN: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
        • Table JAPAN: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table JAPAN: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
        • Table JAPAN: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
        • Table JAPAN: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • CHINA
        • Table CHINA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
        • Table CHINA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
        • Table CHINA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table CHINA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
        • Table CHINA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
        • Table CHINA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • INDIA
        • Table INDIA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
        • Table INDIA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
        • Table INDIA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table INDIA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table INDIA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table INDIA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table INDIA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
        • Table INDIA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
        • Table INDIA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
    • LATIN AMERICA
      • Table LATIN AMERICA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • Table LATIN AMERICA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • LATIN AMERICA: RECESSION IMPACT
      • BRAZIL
        • Table BRAZIL: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
        • Table BRAZIL: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
        • Table BRAZIL: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table BRAZIL: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table BRAZIL: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table BRAZIL: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table BRAZIL: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
        • Table BRAZIL: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
        • Table BRAZIL: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • MEXICO
        • Table MEXICO: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
        • Table MEXICO: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
        • Table MEXICO: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table MEXICO: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table MEXICO: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table MEXICO: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table MEXICO: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
        • Table MEXICO: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
        • Table MEXICO: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • REST OF LATIN AMERICA
        • Table REST OF LATIN AMERICA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
        • Table REST OF LATIN AMERICA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
    • MIDDLE EAST & AFRICA
      • Table MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • Table MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • MIDDLE EAST & AFRICA: RECESSION IMPACT
      • GCC COUNTRIES
        • Table GCC COUNTRIES: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
        • Table GCC COUNTRIES: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
        • Table GCC COUNTRIES: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table GCC COUNTRIES: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/ CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table GCC COUNTRIES: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table GCC COUNTRIES: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table GCC COUNTRIES: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
        • Table GCC COUNTRIES: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
        • Table GCC COUNTRIES: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
      • REST OF MIDDLE EAST & AFRICA
        • Table REST OF MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET, BY OFFERING, 2021-2028 (USD MILLION)
        • Table REST OF MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET, BY REVENUE MODEL, 2021-2028 (USD MILLION)
        • Table REST OF MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table REST OF MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET FOR TREATMENT/CARE-RELATED APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET FOR PREVENTIVE APPLICATIONS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET FOR CNS DISORDERS, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2021-2028 (USD MILLION)
        • Table REST OF MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET FOR B2C SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
        • Table REST OF MIDDLE EAST & AFRICA: DIGITAL THERAPEUTICS MARKET FOR B2B SALES CHANNEL, BY BUYER, 2021-2028 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • KEY PLAYER STRATEGIES
    • REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
      • REVENUE ANALYSIS OF KEY PLAYERS IN DIGITAL THERAPEUTICS MARKET, 2020-2022 (USD MILLION)
    • MARKET SHARE ANALYSIS
      • Table DIGITAL THERAPEUTICS MARKET: INTENSITY OF COMPETITIVE RIVALRY
    • COMPANY EVALUATION MATRIX
      • STARS
      • EMERGING LEADERS
      • PERVASIVE PLAYERS
      • PARTICIPANTS
      • COMPANY FOOTPRINT
        • Table DIGITAL THERAPEUTICS MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
        • Table DIGITAL THERAPEUTICS MARKET: OFFERING FOOTPRINT ANALYSIS, BY KEY PLAYER
        • Table DIGITAL THERAPEUTICS MARKET: APPLICATION FOOTPRINT ANALYSIS, BY KEY PLAYER
        • Table DIGITAL THERAPEUTICS MARKET: SALES CHANNEL FOOTPRINT ANALYSIS, BY KEY PLAYER
        • Table DIGITAL THERAPEUTICS MARKET: REGIONAL FOOTPRINT ANALYSIS, BY KEY PLAYER
    • COMPANY EVALUATION MATRIX FOR STARTUPS/SMES
      • PROGRESSIVE COMPANIES
      • RESPONSIVE COMPANIES
      • DYNAMIC COMPANIES
      • STARTING BLOCKS
      • COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
        • Table DETAILED LIST OF KEY STARTUPS/SMES
        • Table COMPETITIVE BENCHMARKING OF STARTUPS/SMES, BY REGION
    • COMPETITIVE SCENARIOS AND TRENDS
      • Table DIGITAL THERAPEUTICS MARKET: PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS (JANUARY 2020-NOVEMBER 2023)
      • DEALS
        • Table DIGITAL THERAPEUTICS MARKET: DEALS (JANUARY 2020-NOVEMBER 2023)
      • OTHER DEVELOPMENTS
        • Table DIGITAL THERAPEUTICS MARKET: OTHER DEVELOPMENTS (JANUARY 2020-NOVEMBER 2023)
  • COMPANY PROFILES
    • KEY PLAYERS
      • NOOM, INC.
        • Table NOOM, INC.: BUSINESS OVERVIEW
      • TELADOC HEALTH, INC.
        • Table TELADOC HEALTH, INC.: BUSINESS OVERVIEW
      • OMADA HEALTH, INC.
        • Table OMADA HEALTH, INC.: BUSINESS OVERVIEW
      • WELLDOC, INC.
        • Table WELLDOC, INC.: BUSINESS OVERVIEW
      • COGNIFIT, INC.
        • Table COGNIFIT, INC.: BUSINESS OVERVIEW
      • HEADSPACE HEALTH
        • Table HEADSPACE HEALTH: BUSINESS OVERVIEW
      • PROPELLER HEALTH
        • Table PROPELLER HEALTH: BUSINESS OVERVIEW
      • 2MORROW, INC.
        • Table 2MORROW, INC.: BUSINESS OVERVIEW
      • CANARY HEALTH
        • Table CANARY HEALTH: BUSINESS OVERVIEW
      • CLICK THERAPEUTICS, INC.
        • Table CLICK THERAPEUTICS: BUSINESS OVERVIEW
      • AKILI, INC.
        • Table AKILI, INC.: BUSINESS OVERVIEW
      • WELLTHY THERAPEUTICS PVT. LTD.
        • Table WELLTHY THERAPEUTICS PVT. LTD.: BUSINESS OVERVIEW
      • COGNOA, INC.
        • Table COGNOA, INC.: BUSINESS OVERVIEW
      • TWILL INC.
        • Table TWILL INC.: BUSINESS OVERVIEW
      • KAIA HEALTH SOFTWARE GMBH
        • Table KAIA HEALTH SOFTWARE GMBH: BUSINESS OVERVIEW
      • BETTER THERAPEUTICS, INC.
        • Table BETTER THERAPEUTICS, INC.: BUSINESS OVERVIEW
      • REALIZEDCARE
        • Table REALIZEDCARE: BUSINESS OVERVIEW
      • BIOFOURMIS
        • Table BIOFOURMIS: BUSINESS OVERVIEW
      • AYOGO INCORPORATED
        • Table AYOGO INCORPORATED: BUSINESS OVERVIEW
      • AMALGAM RX, INC.
        • Table AMALGAM RX, INC.: BUSINESS OVERVIEW
    • OTHER PLAYERS
      • MINDABLE HEALTH GMBH
      • VIRTA HEALTH CORP.
      • HINGE HEALTH
      • OREXO AB
      • FREESPIRA, INC.
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
    • CUSTOMIZATION OPTIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Market Growth Outlook Summary

The global digital therapeutics market, valued at US$4.4 billion in 2022, is forecasted to grow at a robust CAGR of 29.1%, reaching US$6.1 billion in 2023 and an impressive US$21.9 billion by 2028. The rapid adoption of digital therapeutics is driven by the rising incidence of chronic diseases, surging investments from venture capital firms, and strategic partnerships between tech companies and healthcare providers. One of the most important factors driving growth is the integration of sophisticated digital technologies like AI/ML, wearables, mobile, etc. For instance, in 2022, Mobile Health (US) launched a fully integrated suite of digital therapeutics (DTx) solutions that offers AI-based communication to deliver evidence-based therapeutic interventions. However, lack of clear regulatory guidelines and slow reimbursement processes coupled with substantial development, maintenance, and upgrade costs pose challenge on the adoption of digital therapeutics solutions in the market.

Digital Therapeutics Market Size, Dynamics & Ecosystem

Digital Therapeutics Market Size, Dynamics & Ecosystem

To know about the assumptions considered for the study, Request for Free Sample Report

Digital Therapeutics Market Dynamics

Drivers: Rising focus on Preventative Healthcare

Primary preventive measures can help prevent or arrest the disease in its earliest stages by promoting healthier lifestyles or immunizing against infectious diseases. Many leading causes of death and disability can be prevented with adequate measures. There is a growing consensus among policymakers, providers, and patients that preventive, behavioral, and lifestyle changes are effective pills or procedures.

In the US, chronic conditions account for ~75% of the USD 3.5-trillion annual healthcare spending (Source: chronicdisease.org and the CMS, 2019). However, these chronic diseases are largely preventable. Government legislation and initiatives, such as the Patient Protection and Affordable Care Act (PPACA) (2010), aim at making preventive care affordable and accessible. Owing to the Act, programs incentivizing preventive treatment options are becoming popular.

Restraints: Reluctance among patients to adopt digital therapeutics

Motivating people to use digital therapeutics and building their confidence is a major challenge faced by digital therapeutics providers. While older and underserved populations show maximum susceptibility to diseases and the highest occurrence rates, they are the least likely to use digital therapeutics products due to low technology literacy levels. Furthermore, the limit of how much behavioral change will be observed with digital therapeutics is still undefined.

The clinical validation and deployment of digital therapeutics are carried out on self-selected or volunteer patients; however, their effect on patients showing resistance is still unknown. Furthermore, it is unknown whether digital therapeutics can be sustained over longer periods; there is little information on total patient retention and long-term outcomes. Many patients still rely on traditional means of diagnosis and treatment and thus show reluctance to adopt these novel therapies. This poses a major challenge to the digital therapeutics market.

Opportunities: Large undiagnosed and untreated population

Despite the availability of highly effective and low-cost treatment options for chronic disorders, a large undiagnosed and untreated population still exists. According to the WHO, many people affected by chronic diseases do not get the required treatment and care. According to WHO, in 2019, over one billion people with hypertension (82% of all people with hypertension worldwide) lived in low and middle-income countries. According to BMC Public health Journal 2022, the overall prevalence rates of undiagnosed, untreated, and undertreated hypertension among older adults in India were 42.3%, 6%, and 18.7%, respectively. Approximately 90% of COPD deaths occur in low and middle-income countries, as they do not get the required treatment. Over 75% of CVD-related deaths occur in low and middle-income countries, primarily due to low/limited access to appropriate care. Often, treatment for these conditions is not integrated into primary healthcare—the only access to medical care across these regions.

Hence, the affected population is deprived of the necessary care. Other factors, such as underdeveloped health delivery systems, a lack of trained personnel, the absence of essential drugs, and the prevalence of traditional beliefs and practices, also lead to a significant untreated population. This population presents ample opportunities for the implementation of digital therapeutics. Since digital therapeutics is delivered online, it is more accessible than conventional treatment solutions and can reach more patients.

Challenges: Lack of awareness and access to digital therapeutics programs in developing countries

Healthcare information technology has witnessed significant growth in developing regions owing to healthcare reforms. However, the IT infrastructure is still inadequate to meet the demands and needs of the increasing population in these countries. Most healthcare professionals (HCPs) highlighted a lack of awareness regarding the availability and benefits of digital therapeutics.

In general, there is a lack of knowledge about the efficacy of digital therapeutics and whether these solutions have robust clinical trial data to support their use. This notion is even more prominent in markets with elevated skepticism and conservatism toward digital technology (e.g., Germany and Belgium). Digital health advancements are currently restricted primarily to economically and socially developed regions. As a result, developing regions lack awareness and access to these technological advancements in healthcare. This condition is more pronounced among the underserved populations in the rural areas of developing countries. Some common barriers include a lack of appropriate knowledge about healthcare, lack of competency for using e-health solutions, lack of digital literacy, limited or no access to the Internet, and an overall lack of awareness of digital therapeutics and its advantages.

Digital Therapeutics Market Segmentation & Geographical Spread

Digital Therapeutics Market Segmentation & Geographical Spread

To know about the assumptions considered for the study, download the pdf brochure

The digital therapeutics market ecosystem comprises entities responsible for the end-to-end workflow of digital therapeutics services. The major stakeholders present in this market include network connectivity providers, infrastructure service providers, platform/service/application providers, hospitals and healthcare systems, employers, healthcare payers, government regulatory bodies and start up companies. The demand continues to grow and expand, especially after the outbreak of the COVID-19 pandemic. Solution and service providers continue to enhance and mature their offerings to add value.

Software/Platforms segment is anticipated to garner the highest share during the forecast period.

The digital therapeutics market based on offering is segmented into software/platforms, programs, and virtual reality/games. Software/Platforms is estimated to capture the largest share over the study period. This dominance is driven by the increasing reliance on sophisticated software solutions to deliver therapeutic interventions, reflecting a growing trend toward digital health solutions. The segment’s prominence highlights the crucial role of advanced technologies and platforms in shaping the trajectory of the digital therapeutics market.

Business-to-Buisness segment is anticipated to account for the lion’s share of digital therapeutics market, by Sales in 2022.

The digital therapeutics market is divided based on sales channel into business-to-business (B2B), and business-to-customer (B2C). This is owing to the increasing adoption among payers, employers, and providers understanding the benefits of digital therapeutics. Additionally, the inclination of pharmaceutical companies to incorporate digital therapeutics with their drug products is also estimated to drive the adoption of the products within these end-user segment.

Care-related/Treatment applications are the highest share of the digital therapeutics market, by applications in 2022.

The digital therapeutics market is bifurcated based on applications into care-related/treatment and preventive applications. The growth of the care-related/treatment applications segment is owed to the rising economic burden of their treatment, and investments in digital therapeutics to promote the advancement of cost-effective and scalable treatment platforms for these conditions.

North America to lead the digital therapeutics market in 2022.

The segmentation of the digital therapeutics market based on region, encompasses North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. As of 2022, North America held the dominant market share, with Europe following closely behind. The accelerated growth in North America is primarily ascribed to increased investments in digital therapeutics, improvements in the reimbursement framework for these solutions, a surge in the number of new startups in the digital therapeutics sector, and government initiatives aimed at promoting technological advancements in this region.

Key Market Players

Prominent players in digital therapeutics include Noom, Inc (US), Teladoc Health, Inc. (US), Omada Health, Inc. (US), WellDoc, Inc (US), Biofourmis (US), Better Therapeutics, Inc (US), Amalgm Rx (US), CogniFit Inc (US), Headspace Health (US), Propeller Health (US), Virta Health Corp (US), 2Morrow, Inc. (US), Realizedcare (US), Canary Health (US), Twill Inc. (US), Click Therapeutics, Inc. (US), Akili, Inc. (US), Cognoa, Inc (US), Wellthy Therapeutics Pvt. Ltd. (India), Kaia Health (Germany), Ayogo (Canada), Mindable Health GmbH (Germany), Hinge Health, Inc. (US), and Freespira (US).

The research report categorizes the digital therapeutics market to forecast revenue and analyze trends in each of the following submarkets:

By Offering

  • Programs
  • Software/Platforms
  • Virtual Reality/Games

By Revenue Modal

  • Subscription
  • One time Purchase/Licensing
  • Outcome/Value based

By Sales Channel

  • B2C
  • Patients
  • Caregivers
  • B2B
  • Providers
  • Payers
  • Employers
  • Pharmaceutical Companies
  • Other Buyers

By Application

  • Preventive Applications
  • Prediabetes
  • Obesity
  • Nutrition
  • Lifestyle Management
  • Other Preventive Applications
  • Treatment/Care-related Applications
  • Diabetes
  • CNS Disorders
    • Mental Health Disorder
    • Other CNS Disorders
  • Chronic Respiratory Disorders
  • Musculoskeletal Disorders
  • Cardiovascular Diseases
  • Smoking Cessation
  • Medication Adherence
  • Gastrointestinal Disorders
  • Substance Use & Addiction Management
  • Rehabilitation & Patient Care
  • Other Treatment/Care-related Applications

By Region

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • Rest of Europe (RoE)
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of the APAC
  • Latin America (LATAM)
    • Brazil
    • Mexico
    • Rest of Latin America (RoLATAM)
  • Middle East & Africa (MEA)
    • GCC Countries
    • Rest of Middle East & Africa (RoMEA)

Recent Developments

  • In May 2023, Noom, Inc. announced a new program, Noom Med, designed to fight the disease of obesity. Noom Med is a program that has offers telehealth services with Noom’s personalized psychological tools for patients enrolling for weight loss.
  • In May 2023, Omada Health announced a specialized program enhancement for members taking GLP-1s, in response to the growing interest and demand for the medication.
  • In August 2022, Teladoc Health announced a home A1C (hemoglobin A1C) testing program for its Livongo product to help Teladoc Health members manage and control their diabetes via blood glucose meters.
  • In April 2021, Welldoc (US) partnered with Dexacom (US). This partnership helped provide BlueStar with Dexcom G6 CGM as a single platform to people with Type 2 diabetes for improved health.


★調査レポート[Digital Therapeutics Market / DTx Market by Offerings (Platform, Virtual Reality/Games), Revenue Model (Subscription, Value Based), Application (Therapy (Diabetes, Obesity, CNS, Respiratory, CVD), Drug Adherence, Rehab/Patient care) – Global Forecast to 2028] (コード：HIT 4407)販売に関する免責事項を必ずご確認ください。
★調査レポート[Digital Therapeutics Market / DTx Market by Offerings (Platform, Virtual Reality/Games), Revenue Model (Subscription, Value Based), Application (Therapy (Diabetes, Obesity, CNS, Respiratory, CVD), Drug Adherence, Rehab/Patient care) – Global Forecast to 2028]についてメールでお問い合わせ